Eric Mark Green is CEO & President at WEST PHARMACEUTICAL SERVICES INC (WST). They have made 11 open-market trades across 3 companies since 2009, most recently 2026-09-30.
CIK 0001336007
2 open-market purchases totalling $2.0M since 2015, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WST | 175,160 | $67.2M |
| ECL | 8,233 | $2.4M |
| SIAL | 34,480 | — |
| Total | $69.6M |
Shares reported on the most recent Form 4, priced at the 2026-10-02 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ECL | BUY | 2026-09-11 | 2026-09-14 | $276.64 | $1.0M | -0.7% | +3.8% | — |
| WST | SELL · 10b5-1 | 2024-08-06 | 2024-08-08 | $304.71 | $18.7M | +2.3% | +3.3% | +12.6% |
| WST | SELL · 10b5-1 | 2024-05-07 | 2024-05-09 | $366.65 | $48.4M | -7.8% | -12.5% | -19.6% |
| WST | SELL · 10b5-1 | 2024-02-27 | 2024-02-29 | $359.85 | $46.2M | +6.1% | +11.1% | -9.4% |
| WST | SELL · 10b5-1 | 2023-08-08 | 2023-08-10 | $394.82 | $29.5M | -1.2% | -0.2% | -13.2% |
| WST | SELL | 2023-05-09 | 2023-05-11 | $363.09 | $31.8M | -4.8% | -0.8% | +11.1% |
| WST | SELL | 2023-03-07 | 2023-03-09 | $322.35 | $28.4M | +6.5% | +11.2% | +9.6% |
| WST | SELL | 2022-12-05 | 2022-12-08 | $238.96 | $20.8M | -2.1% | +3.5% | +37.4% |
| WST | BUY | 2015-05-21 | 2015-05-22 | $54.89 | $1.0M | -5.9% | -2.8% | -2.8% |
| SIAL | SELL | 2015-03-12 | 2015-03-16 | $138.20 | $4.3M | N/A | N/A | N/A |
| SIAL | SELL | 2014-05-29 | 2014-05-30 | $98.03 | $445K | N/A | N/A | N/A |
| SIAL | SELL | 2013-05-15 | 2013-05-16 | $83.05 | $324K | N/A | N/A | N/A |
| SIAL | SELL | 2010-10-29 | 2010-11-01 | $63.12 | $347K | N/A | N/A | N/A |
| SIAL | SELL | 2010-02-16 | 2010-02-16 | $48.50 | $243K | N/A | N/A | N/A |
| SIAL | SELL | 2009-09-03 | 2009-09-04 | $49.84 | $244K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.